Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 25)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
9-Feb-10 Pechala's Reports Lubomir Pechala MOLECULAR INSIGHT PHARMACEUTICALS INC (MIPI=US) - REPORT FOR ACTIVE TRADERS 4 $25 View Abstract
8-Feb-10 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for MIPI 13 $25 View Abstract
7-Feb-10 Pechala's Reports Frantisek Pechala MOLECULAR INSIGHT PHARMACEUTICALS INC (MIPI=US) 12-months forecast 1 $15 View Abstract
7-Feb-10 PriceTarget Research, Inc. N/A Biotechnology Intelligence Monitor: overall outlook NEUTRAL - 23 new Leaders; 25 new Laggards. 63 $20 View Abstract
6-Feb-10 Standard & Poor's Quantitative Report N/A Molecular Insight Pharm'ls 6 $25 View Abstract
6-Feb-10 Pechala's Reports Lubomir Pechala MOLECULAR INSIGHT PHARMACEUTICALS INC (MIPI=US) 2-weeks forecast 1 $10 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: MOLECULAR INSIGH -- MIPI 1 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: ANX , MIPI , STEM , TSPT -- DRUGS 3 $4 View Abstract
5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of MOLECULAR INSIGHT PHARMACTLS including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
2-Feb-10 Wall Street Transcript ,The The Wall St Transcript MANAGEMENT TURNOVER REPORT - Molecular Insight Pharmaceuticals, Inc. (MIPI) 11 $50 View Abstract
Next 15

Independent Reports (Showing 1 to 10 of 25)

Release
Date Contributor Author Title Pages Price More Info
9-Feb-10 Pechala's Reports Lubomir Pechala MOLECULAR INSIGHT PHARMACEUTICALS INC (MIPI=US) - REPORT FOR ACTIVE TRADERS 4 $25 View Abstract
8-Feb-10 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for MIPI 13 $25 View Abstract
7-Feb-10 Pechala's Reports Frantisek Pechala MOLECULAR INSIGHT PHARMACEUTICALS INC (MIPI=US) 12-months forecast 1 $15 View Abstract
7-Feb-10 PriceTarget Research, Inc. N/A Biotechnology Intelligence Monitor: overall outlook NEUTRAL - 23 new Leaders; 25 new Laggards. 63 $20 View Abstract
6-Feb-10 Standard & Poor's Quantitative Report N/A Molecular Insight Pharm'ls 6 $25 View Abstract
6-Feb-10 Pechala's Reports Lubomir Pechala MOLECULAR INSIGHT PHARMACEUTICALS INC (MIPI=US) 2-weeks forecast 1 $10 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: MOLECULAR INSIGH -- MIPI 1 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: ANX , MIPI , STEM , TSPT -- DRUGS 3 $4 View Abstract
5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of MOLECULAR INSIGHT PHARMACTLS including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
2-Feb-10 Wall Street Transcript ,The The Wall St Transcript MANAGEMENT TURNOVER REPORT - Molecular Insight Pharmaceuticals, Inc. (MIPI) 11 $50 View Abstract
Next 15

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.